Table 1.
General study population
| Overall (n = 80) | CPS A (n = 30) | CPS B (n = 35) | CPS C (n = 15) | P‐value | |
|---|---|---|---|---|---|
| IIEF‐5, median, (95% CI) | 20 (10‐24) | 21 (11‐24.5) | 19 (10.6‐25) | 16 (9‐16) | .038 |
| Erectile dysfunction, n (%) | 51 (63.8%) | 16 (53.5%) | 22 (62.9%) | 13 (86.7%) | .089 |
| ED severity, n (%) | |||||
| No ED | 29 (36.3%) | 14 (46.7%) | 13 (37.1%) | 2 (13.3%) | .037 |
| Mild‐to‐moderate ED | 44 (55%) | 15 (50%) | 20 (57.1%) | 9 (60%) | |
| Moderate‐to‐severe ED | 7 (8.8%) | 1 (3.3%) | 2 (5.7%) | 4 (26.7%) | |
| Active Relationship, n (%) | 64 (80%) | 24 (80%) | 27 (77%) | 13 (87%) | .593 |
| BT, median (95%CI) | 1.31 (0.14‐2.59) | 1.68 (1.16‐3.51) | 1.2 (0.2‐2.38) | 0.48 (0.12‐0.48) | <.001 |
| TT, median (95% CI) | 5.98 (0.57‐12.46) | 7.32 (4.20‐13.94) | 4.66 (1.14‐9.94) | 2.41 (0.25‐2.41) | <.001 |
| Libido, n (%) | |||||
| Normal | 26 (32.5%) | 13 (50%) | 11 (42.3%) | 2 (7.7%) | .126 |
| Impaired | 54 (67.5%) | 17 (31.5%) | 24 (44.4%) | 13 (24.1%) | |
| Beta‐blockera, n (%) | 40 (53.3%) | 14/28 (46.7%) | 18/33 (51.4%) | 8/14 (53.3%) | .893 |
| Depression, n (%) | 13 (16.3%) | 5 (16.7%) | 7 (20%) | 1 (6.7%) | .502 |
| Anti depressive medication, n (%) | 7 (8.8%) | 4 (13.3%) | 3 (8.6%) | 0 (0%) | .328 |
| Active smoker, n (%) | No: 47 (58.8%) | 14 (29.8%) | 23 (48.9%) | 10 (21.3%) | .235 |
| Yes: 33 (41.3%) | 16 (48.5%) | 12 (36.4%) | 5 (15.2%) | ||
| Art. HTN, n (%) | 26 (32.5%) | 11 (36.7%) | 12 (34.3%) | 3 (20%) | .507 |
| Diabetes, n (%) | 25 (31.3%) | 7 (23.3%) | 14 (40%) | 4 (26.7%) | .322 |
| CVD, n (%) | 4 (5%) | 1 (3.3%) | 3 (8.6%) | 0 (0%) | .386 |
| BMI, mean ± SD | 26.7 ± 4.2 | 26.5 ± 4.7 | 26.7 ± 4.1 | 26.8 ± 3.6 | 1.0 |
| Age, mean ± SD | 53 ± 9 | 50 ± 9 | 55 ± 9 | 53 ± 10 | A vs B: 0.138 A vs C: 0.852 B vs C: 1.0 |
BT, bioavailable testosterone; CPS, Child‐Pugh score; ED, erectile dysfunction;; IIEF‐5, international index of erectile function‐5; TT, total testosterone.
a
BB status was available in 75 patients; in 5 patients, no information on BB intake was available owing to uncertain duration and frequency of BB intake.